Advertisement

Latest News

KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms

55 minutes ago

A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.

Women Experience Sleep Disruptions, Heightened Anger in Days Leading Up to Period

1 hour ago

A new study found sleep and emotional well-being are impacted days before women get their period.

Pegloticase Treatment Associated with Concomitant Bone Remodeling in Gout

12 hours ago

Kenneth Saag, MD, explores the clinical significance of a study demonstrating treatment with pegloticase leads to bone remodeling in patients with gout.

RGX-314 Gene Therapy for nAMD Well-Tolerated in Phase 1/2a Study

14 hours ago

A single administration of ABBV-RGX-314 was generally well tolerated, with little to no supplemental anti-VEGF injections required in most patients at two years.

Diabetes Dialogue: All Things AID at ATTD 2024

15 hours ago

In this episode, all things AID from the 17th annual ATTD, including updates from Insulet Corporation and Omnipod, study data from the Control IQ algorithm, the SMASH study, and a peak into the future with the Neural Network AID algorithm.

Advertisement
Advertisement